Gananandan Kohilan, Kazankov Konstantin, Tapper Elliot B, Mookerjee Rajeshwar P
Liver Failure Group, Institute for Liver and Digestive Health, University College London, London, UK.
Department of Hepatology and Gastroenterology, Aarhus University Hospital, Aarhus, Denmark.
Lancet Digit Health. 2025 Jan;7(1):e54-e63. doi: 10.1016/S2589-7500(24)00174-2. Epub 2024 Nov 20.
There is a growing global burden of liver disease with the current management for complications of liver cirrhosis being reactive as opposed to proactive, affecting outcomes. Management can often be suboptimal in overburdened health-care systems with considerable socioeconomic and geographical disparity existing, which was exacerbated by the COVID-19 pandemic, highlighting the need for sustainable care pathways to be delivered remotely. To this end, digital health care could be the key and, in this Review, we highlight the principal studies that have explored the use of digital technology in the management of cirrhosis complications. While digital health care is a somewhat new field, considerable advances have been made in various domains, particularly in the development of remote monitoring and risk modelling. We aim to provide a balanced perspective of the opportunities for and barriers to the integration of digital technology into established liver-care pathways. Lastly, we reflect on the current acceptability of digital health care and the required future directions to ensure the digital transformation of hepatology is a success.
全球肝病负担日益加重，目前对肝硬化并发症的管理是被动反应式而非主动式的，这影响了治疗效果。在负担过重的医疗保健系统中，管理往往不够理想，存在相当大的社会经济和地理差异，而新冠疫情使这种情况更加恶化，凸显了远程提供可持续护理途径的必要性。为此，数字医疗可能是关键所在，在本综述中，我们重点介绍了探索数字技术在肝硬化并发症管理中应用的主要研究。虽然数字医疗是一个相对较新的领域，但在各个领域都取得了显著进展，尤其是在远程监测和风险建模的发展方面。我们旨在全面审视将数字技术整合到既定肝病护理途径中的机遇和障碍。最后，我们思考了数字医疗目前的可接受性以及未来所需的方向，以确保肝病学的数字化转型取得成功。
